Comorbid mental disorders in subjects at clinical high risk for psychosis (CHR-P) may
impact preventive care. We conducted a PRISMA/MOOSE-compliant systematic meta …

Anxiety symptoms can occur in up to 65% of patients with schizophrenia, and may reach the
threshold for diagnosis of various comorbid anxiety disorders, including obsessive …

The “at risk mental state” for psychosis approach has been a catalytic, highly productive
research paradigm over the last 25 years. In this paper we review that paradigm and …

Background Patients at ultra-high risk for psychosis (UHR) are a highly heterogeneous
group in terms of clinical and functional outcomes. Several non-psychotic mental disorders …

Schizophrenia (SCZ) and major depressive disorder (MDD) in treatment‐naive patients are
associated with increased risk for type 2 diabetes (T2D) and metabolic syndrome (MetS) …

Intervention strategies in adolescents at ultra high-risk (UHR) for psychosis are promising for
reducing conversion to overt illness, but have only limited impact on functional outcome …

The article demonstrates for the first time that a brain-inspired spiking neural network (SNN)
architecture can be used not only to learn spatio-temporal data, but also to extract fuzzy …

Abstract Although the Positive and Negative Syndrome Scale (PANSS) is widely utilized in
schizophrenia research, variability in specific item loading exist, hindering reproducibility …

Anxiety and depression symptoms are frequently experienced by individuals with psychosis,
although prevalence rates have not been reviewed in first-episode psychosis (FEP). The aim …

Background Traditionally, research in the ultra-high risk (UHR) for psychosis population has
focused on the treatment of existing symptomatology and prevention of transition to …